Skip to main content
OpenTrials

Clinical trial condition

Membranous Nephropathy

Explore clinical trials studying Membranous Nephropathy. Study availability and eligibility vary by location and protocol.

34 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Membranous Nephropathy trial results

Recruiting

Belimumab With Rituximab for Primary Membranous Nephropathy

NCT03949855

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • University of Alabama at Birmingham School of Medicine: Division of Nephrology Birmingham, Alabama, United States
  • University of Arkansas Little Rock, Arkansas, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University School of Medicine: Division of Nephrology Stanford, California, United States
View all 20 locations
View Trial Details
Recruiting

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

NCT06341205

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • CHU de BESANCON Besançon, France
  • CHU de BORDEAUX - Hôpital Pellegrin Bordeaux, France
  • CHU de CAEN Caen, France
  • AP-HP - Hôpital H. Mondor Créteil, France
View all 14 locations
View Trial Details
Recruiting

NEPTUNE Match Study

NCT04571658

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +29 more
Locations
  • Emory University Hospital - Children's Hospital of Atlanta Atlanta, Georgia, United States
  • John H. Stroger, Jr., Hospital of Cook County Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Johns Hopkins Medicine Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Recruiting

Nephrotic Syndrome Study Network

NCT01209000

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +15 more
Locations
  • University of Southern California-Children's Hospital Los Angeles, California, United States
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of California San Francisco Benioff Children's Hospitals San Francisco, California, United States
  • Lundquist Biomedical Research Institute at Harbor UCLA Medical Center Torrance, California, United States
View all 44 locations
View Trial Details
Recruiting

An Outcome Analysis of Primary Membranous Nephropathy

NCT06242327

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • ASST HPG23 - Unità di Nefrologia Bergamo, BG, Italy
  • Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica, BG, Italy
View Trial Details
Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

NCT07038382

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +14 more
Locations
  • Beijing Tsinghua Changgung Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Xiangya Hospital Of Gentral South University Changsha, China
  • Guangdong Provincial People's Hospital Guangzhou, China
View all 17 locations
View Trial Details

Related conditions